The report concludes that RRBM reduces the incidence of breast cancer and/or the number of deaths or both.28 Heemskerk-Gerritsen and colleagues concluded from their study that RRBM was associated with lower mortality than surveillance for BRCA1 mutation carriers at the age of 65. This evidence concerns the gene BRCA1 and breast carcinoma.